Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$474K Sell
569
-14
-2% -$12.5K 0.18% 98
2024
Q2
$596K Sell
583
-18
-3% -$17.3K 0.3% 65
2024
Q1
$583K Sell
601
-11
-2% -$9.76K 0.32% 62
2023
Q4
$463K Buy
612
+142
+30% +$93.8K 0.29% 65
2023
Q3
$277K Sell
470
-97
-17% -$64.4K 0.2% 116
2023
Q2
$411K Buy
567
+55
+11% +$37.4K 0.29% 68
2023
Q1
$349K Sell
512
-14
-3% -$8.99K 0.25% 93
2022
Q4
$287K Buy
526
+21
+4% +$11K 0.23% 104
2022
Q3
$210K Buy
505
+7
+1% +$3.51K 0.2% 117
2022
Q2
$237K Buy
498
+22
+5% +$12.3K 0.23% 98
2022
Q1
$318K Buy
476
+56
+13% +$37.5K 0.29% 91
2021
Q4
$334K Buy
+420
New +$334K 0.32% 94

Other funds holding ASML

CEDRUS's ASML Position: Q3 2024 in Review

CEDRUS reduced its ASML (ASML) stake by 2.4% in Q3 2024, selling an estimated $12.5K and leaving 569 shares worth $474K. The position accounts for 0.18% of the portfolio, ranked #98.

CEDRUS first reported a position in ASML in Q4 2021 and has held it in 12 quarters since. The position peaked at $596K in Q2 2024. 1,533 funds tracked by Wall St. Rank hold ASML as of Q3 2024.

  • CEDRUS held 569 shares of ASML worth $474K as of Q3 2024.
  • CEDRUS sold 14 ASML shares in Q3 2024, an estimated $12.5K.
  • ASML made up 0.18% of CEDRUS's portfolio in Q3 2024, its #98 holding.
  • CEDRUS first reported a position in ASML in Q4 2021 and has held it in 12 quarters since.
  • CEDRUS's ASML position peaked at $596K in Q2 2024.
  • 1,533 funds tracked by Wall St. Rank held ASML as of Q3 2024.

Based on CEDRUS's 13F filing for Q3 2024, filed 18 Oct 2024.